By Owen Tucker-Smith
Becton Dickinson is expanding production of medical devices to meet demand from the U.S. health care system, the company said Wednesday.
The Franklin Lakes, N.J., company, which makes medical devices including syringes, diagnostic tests and surgical supplies, has already added new needle and syringe production lines at its plants in Connecticut and Nebraska. One of those lines is fully operational and others are set to start up in the coming months.
Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has hired over 215 staffers in Nebraska and Connecticut to support the effort.
In Utah, BD is set to spend over $30 million to boost its production of IV lines this year, after spending $2 million for IV line improvements last year.
BD runs more than 30 facilities across the U.S., employing over 10,000 people. It is expected to report earnings in February for its first quarter, with analysts expecting a profit of $865.6 million.
Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com
(END) Dow Jones Newswires
January 15, 2025 07:50 ET (12:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.